Overexpression of FOXC1 correlates with poor prognosis in gastric cancer patients.
about
Tumor Hypoxia Regulates Forkhead Box C1 to Promote Lung Cancer ProgressionA novel long non-coding RNA FOXCUT and mRNA FOXC1 pair promote progression and predict poor prognosis in esophageal squamous cell carcinoma.FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance.FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort.FOXC1 promotes melanoma by activating MST1R/PI3K/AKT.FOXC1 promotes proliferation and epithelial-mesenchymal transition in cervical carcinoma through the PI3K-AKT signal pathway.Deregulated FOX genes in Hodgkin lymphoma.FOXC1: an emerging marker and therapeutic target for cancer.Effects of targeted silencing of FOXC1 gene on proliferation and in vitro migration of human non-small-cell lung carcinoma cells.FoxC1 promotes epithelial-mesenchymal transition through PBX1 dependent transactivation of ZEB2 in esophageal cancer.Forkhead box C1 is targeted by microRNA-133b and promotes cell proliferation and migration in osteosarcomaCharacterization of the genomic architecture and mutational spectrum of a small cell prostate carcinomaScreening Driving Transcription Factors in the Processing of Gastric Cancer.Knockdown of long non-coding RNA XIST increases blood-tumor barrier permeability and inhibits glioma angiogenesis by targeting miR-137.The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemia.FOXC1 in cancer development and therapy: deciphering its emerging and divergent roles.miR-582-5p inhibits invasion and migration of salivary adenoid cystic carcinoma cells by targeting FOXC1.MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1.Research progress on the forkhead box C1.Down-regulation of MicroRNA-133 predicts poor overall survival and regulates the growth and invasive abilities in glioma.Silencing FOXC1 inhibits growth and migration of human oral squamous cell carcinoma cellsLong noncoding RNA SNHG6 promotes the progression of colorectal cancer through sponging miR-760 and activation of FOXC1
P2860
Q33588186-3415D4D0-5458-44FE-B61C-F3C4375952B0Q33898799-19581C8F-12C2-47ED-915C-970361F04DC4Q37619126-8D00D523-730A-409C-AB57-C6B59C81EA8CQ37689013-5C791490-C89B-4193-BBD4-09805C9303ABQ37708952-46026FDB-C228-4F08-BCA5-0446AB505184Q37733027-8C0E7378-A1A2-464A-9D37-CA74CEF20BA7Q38973626-E0198315-9F64-444D-B499-0B3B62B3737FQ39176111-4B3FD4DF-9EE6-4C3C-AD13-87E45BBFA8EEQ41003401-FAF5B7BB-E8E7-4B2C-A823-946DC220E424Q41547588-3EF8A23E-77DB-429B-93DE-D25ACEDE1921Q41623598-D97F3044-A1B1-4F7A-AEA7-227249DE7906Q41873815-0B98A805-A3E5-49AA-9DC5-8F850EAC76F0Q42160706-942D66C0-12EA-41BB-A450-D8722A412EE8Q42339290-90764CC0-61E0-436B-ACC8-2F20407C73F6Q43914090-5F85E716-1E5C-414D-8C48-12492BEFE27EQ49624286-30483CE4-D77B-4823-95E7-AF36E45B186AQ50596382-F2DD349E-0B50-4707-84D0-A8531B3C8CB0Q53542144-6C0F5247-A319-43E6-AC8F-FEDBB1B4D1FAQ53701147-78DA46BF-2008-4931-8FD5-C9C010912879Q55458536-74EC6DAD-410E-4F28-BE24-92F7A0AF22EEQ58733344-3E986C8A-BC92-4995-A1D6-33A39D9DE2B0Q58746865-ECD53C52-8381-4549-BC76-F5BAF7DF5F38
P2860
Overexpression of FOXC1 correlates with poor prognosis in gastric cancer patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Overexpression of FOXC1 correlates with poor prognosis in gastric cancer patients.
@en
Overexpression of FOXC1 correlates with poor prognosis in gastric cancer patients.
@nl
type
label
Overexpression of FOXC1 correlates with poor prognosis in gastric cancer patients.
@en
Overexpression of FOXC1 correlates with poor prognosis in gastric cancer patients.
@nl
prefLabel
Overexpression of FOXC1 correlates with poor prognosis in gastric cancer patients.
@en
Overexpression of FOXC1 correlates with poor prognosis in gastric cancer patients.
@nl
P2093
P2860
P356
P1433
P1476
Overexpression of FOXC1 correlates with poor prognosis in gastric cancer patients.
@en
P2093
P2860
P304
P356
10.1111/HIS.12347
P577
2014-02-12T00:00:00Z